commercial prostate tumor tissue microarrays (SuperBioChips)
90
Structured Review
SuperBioChips
commercial prostate tumor tissue microarrays
Commercial Prostate Tumor Tissue Microarrays, supplied by SuperBioChips, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/maxarray%E2%84%A2+human+prostate+microarray+slides/human+prostate+tissue+array/pmc02659745-264-3-26
Average 90 stars, based on 1 article reviews
Commercial Prostate Tumor Tissue Microarrays, supplied by SuperBioChips, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/maxarray%E2%84%A2+human+prostate+microarray+slides/human+prostate+tissue+array/pmc02659745-264-3-26
Average 90 stars, based on 1 article reviews
commercial prostate tumor tissue microarrays - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Crosstalk between Prostate Cancer Cells and Tumor-Associated Fibroblasts Enhances the Malignancy by Inhibiting the Tumor Suppressor PLZF Article Snippet: Human prostate cancer tissue arrays were purchase from Article Title: Elevated NF-κB/SHh/GLI1 Signature Denotes a Worse Prognosis and Represent a Novel Potential Therapeutic Target in Advanced Prostate Cancer Article Snippet: Article Title: Targeting PKLR/MYCN/ROMO1 signaling suppresses neuroendocrine differentiation of castration-resistant prostate cancer Article Snippet: Immunohistochemical (IHC) staining The tissue microarray (TMA) set, which included 40 cases of prostatic carcinoma and 10 cases of benign prostatic tissue, was purchased from Immunohistochemistry:Article Title: Loss of EGR3 is an independent risk factor for metastatic progression in prostate cancer. Article Snippet: Identification of pro-metastatic genomic alterations is urgently needed to help understand and prevent the fatal course of prostate cancer.. Here, we found that the transcription factor EGR3, located at chromosome 8p21.3, is a critical metastasis suppressor.. Aberrant deletion of EGR3 was found in up to 59.76% (deep deletions, 16.87%; shallow deletions, 42.89%) of prostate cancer patients. Article Title: Peptide-conjugated nanoparticles for targeting, imaging, and treatment of prostate cancer Article Snippet: .. Binding Analysis of Phage Clones to Clinical Tumor Surgical Specimens by Immunohistochemistry A Tissue:Article Title: Mucosa-Associated Lymphoid Tissue 1 Is an Oncogene Inducing Cell Proliferation, Invasion, and Tumor Growth via the Upregulation of NF-κB Activity in Human Prostate Carcinoma Cells Article Snippet: .. The Binding Assay:Article Title: Peptide-conjugated nanoparticles for targeting, imaging, and treatment of prostate cancer Article Snippet: .. Binding Analysis of Phage Clones to Clinical Tumor Surgical Specimens by Immunohistochemistry A Clone Assay:Article Title: Peptide-conjugated nanoparticles for targeting, imaging, and treatment of prostate cancer Article Snippet: .. Binding Analysis of Phage Clones to Clinical Tumor Surgical Specimens by Immunohistochemistry A Microarray:Article Title: Peptide-conjugated nanoparticles for targeting, imaging, and treatment of prostate cancer Article Snippet: .. Binding Analysis of Phage Clones to Clinical Tumor Surgical Specimens by Immunohistochemistry A |